<--- Back to Details
First PageDocument Content
Research / Clinical research / Design of experiments / Pharmacy / Canadian Agency for Drugs and Technologies in Health / Pharmaceuticals policy / Clinical trial / Comparative effectiveness research / Canadian Institutes of Health Research / Health / Pharmaceutical sciences / Pharmacology
Date: 2014-02-22 14:55:13
Research
Clinical research
Design of experiments
Pharmacy
Canadian Agency for Drugs and Technologies in Health
Pharmaceuticals policy
Clinical trial
Comparative effectiveness research
Canadian Institutes of Health Research
Health
Pharmaceutical sciences
Pharmacology

Drug Safety and Effectiveness Network Guidance Document for

Add to Reading List

Source URL: www.cihr-irsc.gc.ca

Download Document from Source Website

File Size: 740,02 KB

Share Document on Facebook

Similar Documents

Medicine / Bibliographic databases / Medical research / Canadian Agency for Drugs and Technologies in Health / Healthcare in Canada / Pharmaceuticals policy / Gray literature / Grey Literature Network Service / CINAHL / Library science / Science / Knowledge

Grey Matters! Identifying grey literature for health technology assessments and systematic reviews HTAi 2011 Workshop Hayley Fitzsimmons MLIS - CADTH

DocID: 1aQy9 - View Document

Prediction / Medical technology / Health technology assessment / Technology assessment / Canadian Agency for Drugs and Technologies in Health / HTML Application / High Tech Academy / European Network for Health Technology Assessment / Evaluation / Impact assessment / Technology

LOCAL HEALTH TECHNOLOGY ASSESSMENT DECISION SUPPORT PROGRAM: Program Review and Adaptation Manual Developed by Paule Poulin (Project Lead)

DocID: 1aoE1 - View Document

Feedback / Canadian Agency for Drugs and Technologies in Health / Healthcare in Canada / Pharmaceuticals policy

Feedback on Phase II of pCODR Transfer to CADTH Summary Report Organization Providing Feedback Contact Person *

DocID: 1amFt - View Document

Feedback / Canadian Agency for Drugs and Technologies in Health / Healthcare in Canada / Pharmaceuticals policy

Feedback on Phase II of pCODR Transfer to CADTH Summary Report Organization Providing Feedback Contact Person *

DocID: 1a9M5 - View Document

Impact assessment / Ethology / Prediction / Health technology assessment / Technology assessment / European Network for Health Technology Assessment / Medical technology assessment / Canadian Agency for Drugs and Technologies in Health / Business ethics / Technology / Medical technology / Evaluation

OPEN ACCESS Research Article Why not integrate ethics in HTA: identification and assessment of the reasons

DocID: 17Qrp - View Document